Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Tetracyclic sesterpenoid phytotoxin.
Isoflavone, phytoestrogen found in soy; ER agon...
MEK1/2 inhibitor.
Benzoylurea, insect growth regulator; chitin sy...
Coccidiostat, GAPDH inhibitor.
Taxane synthesis intermediate.
NO donor.
Sesquiterpene lactone derived from Artemesia.
Retinoid, differentiation inducer.
Efflux pump inhibitor
Triazole; demethylation inhibitor.
Synthetic derivative of selenocyanate.
Endogenous opioid peptide; μOr agonist.
JNK, ALK, p38 MAPK inhibitor.
Bioactive compound from olive tree.
Indole derivative found in Isatis, Calanthe, an...
G-quadruplex ligand; DNA breakage inducer.
SIRT1/2 inhibitor, indirect p53 activator.
Used to prevent chromium deficiency and to decr...
Glycoprotein IIb/IIIa inhibitor.